Cargando…

The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression

The NADPH oxidase NOX4 plays a tumor‐suppressor function in HCC. Silencing NOX4 confers higher proliferative and migratory capacity to HCC cells and increases their in vivo tumorigenic potential in xenografts in mice. NOX4 gene deletions are frequent in HCC, correlating with higher tumor grade and w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peñuelas‐Haro, Irene, Espinosa‐Sotelo, Rut, Crosas‐Molist, Eva, Herranz‐Itúrbide, Macarena, Caballero‐Díaz, Daniel, Alay, Ania, Solé, Xavier, Ramos, Emilio, Serrano, Teresa, Martínez‐Chantar, María L., Knaus, Ulla G., Cuezva, José M., Zorzano, Antonio, Bertran, Esther, Fabregat, Isabel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles: Liver Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344438/ https://www.ncbi.nlm.nih.gov/pubmed/35920301 http://dx.doi.org/10.1002/hep.32702

Ejemplares similares

The TGF-β/NADPH Oxidases Axis in the Regulation of Liver Cell Biology in Health and Disease
por: Herranz-Itúrbide, Macarena, et al.
Publicado: (2021)

Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in hepatocellular carcinoma
por: Espinosa-Sotelo, Rut, et al.
Publicado: (2023)

The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination
por: Crosas-Molist, E, et al.
Publicado: (2017)

NADPH oxidase 4 (Nox4) deletion accelerates liver regeneration in mice
por: Herranz-Itúrbide, M., et al.
Publicado: (2020)

Role of NADPH oxidases in the redox biology of liver fibrosis
por: Crosas-Molist, Eva, et al.
Publicado: (2015)

NADPH Oxidase NOX4 Mediates Stellate Cell Activation and Hepatocyte Cell Death during Liver Fibrosis Development
por: Sancho, Patricia, et al.
Publicado: (2012)

Alpha‐fetoprotein‐adjusted‐to‐HCC‐size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma
por: Meischl, Tobias, et al.
Publicado: (2021)

Selective internal radiation therapy (SIRT) for hepatocellular carcinoma (HCC): informing clinical practice for multidisciplinary teams in England
por: Reeves, Helen L, et al.
Publicado: (2022)

Epithelial–Mesenchymal Transition (EMT) Induced by TGF-β in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism
por: Soukupova, Jitka, et al.
Publicado: (2021)

NOX, NOX Who is There? The Contribution of NADPH Oxidase One to Beta Cell Dysfunction
por: Taylor-Fishwick, David A.
Publicado: (2013)

The NADPH Oxidase Nox4 and Aging in the Heart
por: Ago, Tetsuro, et al.
Publicado: (2010)

The Role of the NADPH Oxidase NOX2 in Prion Pathogenesis
por: Sorce, Silvia, et al.
Publicado: (2014)

Structure of the core human NADPH oxidase NOX2
por: Noreng, Sigrid, et al.
Publicado: (2022)

Downregulation of Epidermal Growth Factor Receptor in hepatocellular carcinoma facilitates Transforming Growth Factor-β-induced epithelial to amoeboid transition
por: López-Luque, Judit, et al.
Publicado: (2019)

Physiological roles of NOX/NADPH oxidase, the superoxide-generating enzyme
por: Katsuyama, Masato, et al.
Publicado: (2012)

The NOX toolbox: validating the role of NADPH oxidases in physiology and disease
por: Altenhöfer, Sebastian, et al.
Publicado: (2012)

The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts
por: Liang, Shuang, et al.
Publicado: (2016)

Function of NADPH Oxidases in Diabetic Nephropathy and Development of Nox Inhibitors
por: Lee, Sae Rom, et al.
Publicado: (2020)

Implication of type 4 NADPH oxidase (NOX4) in tauopathy
por: Luengo, Enrique, et al.
Publicado: (2021)

Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

CXCR4 Expression Predicts Early Liver Recurrence and Poor Survival After Resection of Pancreatic Adenocarcinoma
por: Liao, Wei-Chih, et al.
Publicado: (2012)

Salford alcohol assertive outreach team: a new model for reducing alcohol-related admissions
por: Hughes, Neill R, et al.
Publicado: (2013)

Acute kidney injury is independently associated with death in patients with cirrhosis
por: Scott, Robert A, et al.
Publicado: (2013)

The Royal Free Hospital Score: A Calibrated Prognostic Model for Patients With Cirrhosis Admitted to Intensive Care Unit. Comparison With Current Models and CLIF-SOFA Score
por: Theocharidou, Eleni, et al.
Publicado: (2014)

Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients
por: Anty, Rodolphe, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
por: Dyson, Jessica K, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease: a practical approach to treatment
por: Dyson, J K, et al.
Publicado: (2014)

CT With Hepatic Arterioportography as a Pretreatment Examination for Hepatocellular Carcinoma Patients: A Randomized Controlled Trial
por: Ohki, Takamasa, et al.
Publicado: (2013)

Analysis of Notch and TGF-β Signaling Expression in Different Stages of Disease Progression During Hepatitis B Virus Infection
por: Trehanpati, Nirupama, et al.
Publicado: (2012)

Hepatitis B in pregnancy
por: Dyson, Jessica Katharine, et al.
Publicado: (2014)

Network and satellite arrangements in liver disease
por: O'Grady, John G
Publicado: (2013)

Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h
por: McPherson, Stuart, et al.
Publicado: (2016)

Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls
por: Hallsworth, Kate, et al.
Publicado: (2015)

Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents
por: Shiffman, Mitchell L, et al.
Publicado: (2016)

A Tissue-Based Comparative Effectiveness Analysis of Biomarkers for Early Detection of Colorectal Tumors
por: Ahmed, Deeqa, et al.
Publicado: (2012)

A Comprehensive Analysis of Common Genetic Variation Around Six Candidate Loci for Intrahepatic Cholestasis of Pregnancy
por: Dixon, Peter H, et al.
Publicado: (2014)

Non-invasive markers of liver fibrosis in fatty liver disease are unreliable in people of South Asian descent
por: De Silva, Sampath, et al.
Publicado: (2018)

The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)
por: Hudson, Mark, et al.
Publicado: (2017)

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
por: McPherson, Stuart, et al.
Publicado: (2017)

Patient understanding of liver cirrhosis and improvement using multimedia education
por: Goldsworthy, Matthew A, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i5frit3jao3gn9r42sopg2464e